Drug distributors could sue Czech Ministry
The Czech drug distribution industry body, the AVEL, has said it may sue the Health Ministry over debts, estimated at around 88.0 million euros ($105.2 million), for drug deliveries incurred by the hospitals and pharmacies unless the government issues guarantees to cover the non-payment. Health Minister David Rath has said the Ministry will ensure supplies if the AVEL companies pull out. The Ministry has declined to say which pharmaceutical distributor would step in, but has confirmed that it is a Czech company.
The drug distributors also say they are concerned about a new measure from the Ministry going through Parliament which would allow hospitals to sign contracts with health funds, which they believe would mean even more of them with a backlog of delayed payments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze